May 31, 2017
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Alimera Sciences reports $6.7 million quarterly net loss
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
A first-quarter net loss of $6.7 million was reported by Alimera Sciences, compared with an $11.1 million net loss for the first quarter of 2016.
Operating expenses went down from $14.2 million in 2016’s first quarter to $11.5 million in 2017’s first quarter, according to a press release. Research, development and medical affairs expenses went down approximately 30% to $2.1 million.
Net revenue increased by about 14%, from $5.8 million in 2016 to $6.6 million in 2017. International revenue went up from $1.7 million to $2.2 million, while U.S. revenue increased from $4.1 million to $4.4 million.